Finance Minister Arun Jaitley may accord enhanced tax incentives for research and development (R&D) activities in the pharmaceutical sector in the forthcoming Budget to be announced on February 28.
In its Budget proposals, the Commerce Ministry has sought "weighted average tax benefit of 400 per cent for R&D activities for the sector", a senior official told PTI..
Read our full coverage on Union Budget
"There is an urgent need to boost R&D in the pharma sector. India is the hub of generic medicines. It contributes significantly to the country's total exports," the official added.
Annually, India exports pharmaceutical products worth $ 10 billion. The market size of the industry is around Rs 1 lakh crore.
The need for special financial package for the pharma sector has been highlighted in various fora.
The pharma sector is a capital intensive sector. Besides R&D expenditure, regulatory requirements require large funds, an industry expert said.
"All quality investments should be treated on par with R&D to provide incentives to the industry," the official added.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.